Company profile

Implanet designs, produces, and sells medical implants and devices used in orthopedic surgery. The group's products include prosthetic knees, spinal bracing systems, intersomatic cages, pins, suture threads, screws, anchors, etc. Net sales break down by activity as follows:
  • spine surgery (61.5%);
  • knee Surgery (38.5%).
Net sales break down geographically as follows: France (53.4%), the United States (29.2%), Brazil (7.3%) and other (10.1%).

Source: Cofisem - Last Update: 15 Oct 2020
Key Executives
Chief Executive Officer Ludovic Lastennet
Administrative & Finance Director David Dieumegard
Director Research & Development Régis Le Couedic
VP, Communication Nicolas Marin
VP, Financial Communication
Investor Relations Director
Source: Cofisem - Last Update: 03 Jul 2020
Key figures
Millenium 2019 2018 2017 2016 2015
Net sales 7,407 6,720 7,841 7,825 6,653
Income from ordinary activities 7,407 6,720 7,841 7,825 6,653
Operating income -3,434 -5,369 -6,238 -6,881 -7,634
Cost of financial indebtedness net -658 -585 -638 -583
Equity-accounted companies contribution to income
Net profit from discontinued activities
Net income -3,645 -5,551 -6,612 -7,288 -8,008
Net income (Group share) -3,645 -5,551 -6,612 -7,288 -8,008
Fiscal year end 12.19 12.18 12.17 12.16 12.15
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - thousands EUR - thousands EUR - thousands EUR - thousands EUR - thousands
Account Standards
Source: Cofisem - Last Update: 15 Oct 2020
Shareholder information
Free float 69.81 %
Managers and Associates 6.01 %
Nice & Green 3.56 %
European Select Growth Opportunities Fund 2.74 %
Financial investors 1.87 %
Treasury stock 0.34 %
Other shareholders 0.05 %
Source: Cofisem - Last Update: 03 Jul 2020

Financial analysis

Equity research report, in partnership with Morningstar

View Report

Address

Implanet SA

Technopole Bordeaux Montesquieu Allée François Magendie
FR-33650 Martillac
France
Source: Cofisem - Last Update: 15 Oct 2020